Maryland Rising

MARYLAND RISING The University of Maryland School of Pharmacy’s Expertise, Influence, and Impact

In 2010, the University of Maryland School of Pharmacy cut the ribbon to Pharmacy Hall Addition, ushering in a new era of expansion. That same year, we launched a new strategic plan that would guide the School through the next five years.

The role of pharmacy and the pharmacist in health care is evolving, and the University of Maryland School of Pharmacy remains at the forefront of the evolution, anticipating the needs of the profession and developing academic, research, and practice programs that are innovative and proactive. Five years later, we reflect on the tremendous growth that has taken place in each of our strategic areas: education, practice, research, entrepreneurship, and environment.

E D U C AT I O N

2010-15 STRATEGIC

PRACTICE RESEARCH ENTREPRENEURSHIP

PLAN

ENVIRONMENT

For the last 10 years or so, pharmacists have been more involved in patient-directed care. We have incorporated into our academic programs more experiences where students are interacting with patients. These include programs where students are tested on their ability to effectively communicate, provide care, and be clear in their interaction with patients in a culturally sensitive manner.

— DEAN NATALIE D. EDDINGTON, PHD ’89, BSP, FAAPS, FCP

EDUCATION PharmD PROGRAM

Despite rigorous competition for PharmD students in Maryland, both the quality and quantity of applicants to the University of Maryland School of Pharmacy have remained consistent: CLASS

NUMBER OF APPLICANTS

PERCENTAGE WITH UNDERGRADUATE DEGREE OR HIGHER

AVERAGE GPA

2011 1,220

87%

3.43

2012

77%

3.41

2013 959

86%

3.38

2014 1,232

93%

3.43

2015

89%

3.41

1,105

1,216

640 10

cap s u le

www.pharmacy.umaryland.edu

Current PharmD Student Enrollment

15%

Average PharmD class acceptance rate

EDUCATION

6

UMSOP in Baltimore

PhD PROGRAMS PHARMACEUTICAL SCIENCES (PSC)

UMSOP at Shady Grove

PHARMACEUTICAL HEALTH SERVICES RESEARCH (PHSR)

49 NUMBER OF

TOTAL STUDENTS ENROLLED IN 2014-2015

GREENBELT

Noted as one of the best programs of its kind in the country by an external group of reviewers during its 2014 University System of Maryland program review

27 NUMBER OF

TOTAL STUDENTS ENROLLED IN 2014-2015

30 FALL 2012

34

FALL 2014

RESIDENCIES & FELLOWSHIPS

SPRING 2014

2015

Shady Grove has enabled the School to create new and enhanced partnerships in the Washington, D.C., region, including:

54

■ ■ ■ ■ ■ ■ ■

FALL 2014

52 UMSOP PharmD graduates matched

to postgraduate year one (PGY1) residency training positions, an 84 percent match rate

Residency programs are growing in popularity as pharmacy students seek training to help them obtain more specialized roles within the health system setting.

The School of Pharmacy, in partnership with the University of Maryland Medical Center, is home to 16 ASHP-accredited PGY1 and PGY2 residencies and fellowships.

The PharmD program has been offered at the Universities at Shady Grove campus in Rockville, Md., since 2007.

A quarter of all of the School’s PharmD graduates are trained at Shady Grove.

THE MASTER OF SCIENCE IN REGULATORY SCIENCE TOTAL STUDENT ENROLLMENT

46

Greatest percentage of successful PGY1 matches among Big Ten pharmacy schools Among the top 10 in total number of PGY1 matches of all U.S. pharmacy schools

2010

CAPITOL HILL

SHADY GROVE

ONLINE MASTER’S PROGRAMS THE MASTER OF SCIENCE IN PHARMACOMETRICS TOTAL STUDENT ENROLLMENT

COLLEGE PARK SILVER SPRING

26 PharmD graduates reported

matching to residency or fellowship training

American Pharmacists Association Food and Drug Administration Holy Cross Hospital MedImmune, Inc. MedStar Georgetown University Hospital Mercy Health Clinic National Institutes of Health

■ Primary Care Coalition of Montgomery County ■ Shady Grove Adventist Hospital ■ Walter Reed National Military Medical Center

DISTANCE EDUCATION ON THE RISE Distance-learning technology brings learning to those off-site. There has been a rise in the number of distance education credit courses offered from both the PharmD and the master’s degree programs:

2014

57

2013

55

2012

51

2011

48

2010

49

FOCUS ON INTERPROFESSIONAL EDUCATION

2013

Interprofessional education (IPE) remains a priority at the School of Pharmacy. In Maryland and nationally, pharmacists have an increasing role on health care teams due to the Affordable Care Act and their ability to serve the complex needs of diverse patient populations The School joined the Universitywide Center for IPE, with Heather Congdon, PharmD, BCPS, CDE, associate professor of pharmacy practice and science and assistant dean for Shady Grove, as its co-director. Each year, students, faculty, and staff from across the University of Maryland, Baltimore (UMB) gather for UMB’s annual IPE Day. During the event, faculty and students work in teams on realistic and complex patient scenarios.

25% of the School’s students and faculty have

participated in IPE Day each year since its launch.

Participation will soon be a requirement for all second-year PharmD students.

An increasing number of School of Pharmacy faculty are pursuing IPE collaborations such as team teaching and developing course material with someone affiliated with another University System of Maryland (USM) institution, going from 23 percent in 2010 to 38 percent in 2014

The School of Pharmacy and its practice partners are working with Prince George’s County in Maryland, a traditionally underserved community, to develop an interprofessional team-based care model of NPs and PharmDs to manage the high incident of chronic diseases in this patient population. summ e r 201 5

11

PRACTICE As a leader in pharmacy practice, the School of Pharmacy improves the health of people through innovation, collaboration, and advocacy.

Faculty provide specialized pharmacy services at a wide range of locations, including outpatient clinics, hospital units, mental health institutions, skilled nursing care facilities, community pharmacies, and academic health science centers. These practitioners have pioneered new roles for pharmacists in advanced clinical practice by supporting and teaching patients, students, residents, and health care practitioners regarding the best use of medicines.

Innovative programs developed at the School of Pharmacy have taken root and grown throughout the state because they work — empowering patients while improving clinical outcomes, decreasing costs, and enhancing continuity of care.

PRACTICE ENGAGEMENT

NUMBER OF PRACTICE SITES SERVED

NUMBER OF HOURS ENGAGED IN PRACTICE

NUMBER OF INPATIENT ENCOUNTERS

20

21,464

18,694

7,170

2012 24

22,976

19,003

7,236

2013 32

33,612

21,645

7,443

2014 39

39,601

24,045

9,609

2015* 39

42,250

26,500

10,500

YEAR

2011*

Practice sites, practice hours, and patient encounters — 2011 to 2015:

NUMBER OF OUTPATIENT ENCOUNTERS

*Estimated based on six months of available data

P3 EXPANSION

The Maryland Patients, Pharmacists, Partnerships (P3) Program, begun in 2006 and directed by Magaly Rodriguez de Bittner, PharmD, professor of pharmacy practice and science, is an important model of the power of community partnerships. Through the program, specially trained pharmacist coaches apply a model of care that provides step-by-step guidance in medication adherence, lifestyle changes, and self-care skills. Among its accomplishments over the last five years: EXPANSION TO MARYLAND, GEORGIA, TEXAS, VIRGINIA, LOUISIANA, AND CALIFORNIA

PRIOR AUTHORIZATION PROGRAMS ANTIPSYCHOTICS IN CHILDREN AND ADOLESCENTS

Led by Raymond Love, PharmD, professor of pharmacy practice and science

- - - -

Prior authorization and prescriber education for Medicaid Collect baseline patient data Educate prescribers about key issues Approve, negotiate or deny authorization 60% DECREASE IN POLYPHARMACY MORE THAN 40% DECREASE IN ANTIPSYCHOTIC USE MORE THAN $6

million SAVINGS PER YEAR

Pilot project offered to 5,000 state of Maryland employees in 2014

VIRAL HEPATITIS C 2010

P3

Recognized with the American Pharmacists Association (APhA) Foundation’s Pinnacle Award

2012 Recognition in Centers for Disease Control and Prevention program guide as national model for patientpharmacists partnerships

MARYLAND POISON CENTER – AN EVOLVING RESOURCE In addition to providing a valuable service to the community, 24 hours a day, seven days a week, for the last 43 years, the Maryland Poison Center, directed by Bruce Anderson, PharmD, professor of pharmacy practice and science, partnered in 2015 with the Maryland Department of Health and Mental Hygiene’s Overdose Response Program to track the administration of naloxone, a medication used to treat opioid overdoses.

24 NUMBER OF SCHOOL OF PHARMACY EMPLOYEES WHO MAINTAIN THE CENTER

2014 MPC CALL VOLUME

48,407 31,055 human exposures 17,352 animal exposures and requests for information

Led by Lauren Hynicka, PharmD, assistant professor of pharmacy practice and science

- -

-

-

Very costly regimens Rapidly evolving evidence for the standard of care and best practices Medicaid, managed care organizations (MCOs), and the School of Pharmacy have developed prescribing and usage criteria School of Pharmacy reviews data from MCO claims to Medicaid to ensure they meet the criteria

Early results show cost savings and treatment durations dropping from 24 weeks to 12 weeks

MENTAL HEALTH PROGRAM The School’s Mental Health Program (MHP), directed by Raymond Love, PharmD, professor of pharmacy practice and science, partners with the Maryland Department of Health and Mental Hygiene to improve medication use and safety for patients who are served by Behavioral Health Administration facilities or Maryland Medicaid Pharmacy Program.

Faculty and staff members coordinate and provide clinical and distributive pharmacy services to state psychiatric facilities, developmental disabilities, county behavioral health, and substance abuse programs.

Buprenorphine/naloxone maintenance clinic employing collaborative drug therapy management with advanced practice pharmacist

91%

appointment adherence rate

100% six-month retention rate month retention 73% 12 rate per urine bu98% adherence prenorphine testing drug screens negative 88% urine for opioids (non-buprenorphine)

RESEARCH The FDA has carved out funding for research projects that address issues they’re seeing in the use of medication.

The results of those studies led to the FDA developing guidances that pharmaceutical companies and regulators use to sell drugs. The School of Pharmacy has been involved in a number of FDA grants focusing on clinical studies related to generic drugs and drug delivery.

— DEAN NATALIE D. EDDINGTON, PHD ’89, BSP, FAAPS, FCP

INTERNATIONAL PARTNERSHIPS

THE PETER LAMY CENTER FOR DRUG THERAPY AND AGING

The School of Pharmacy is pursuing a partnership with Hospital 57357, a pediatric cancer hospital in Cairo, Egypt, to work with its leaders and those from the affiliated Health Sciences Academy to develop training, education, research, and practice opportunities for its pharmacists and researchers.

The Peter Lamy Center for Drug Therapy and Aging aims to improve drug therapy for aging adults; produce new scientific knowledge with practical applications for improving the outcomes of pharmaceutical care for older adults; and provide information on best practices in geriatric pharmacotherapy.

In May 2015, UMB signed a MOU with Ajou University in South Korea on behalf of the School of Pharmacy to promote areas of mutual interest in faculty exchange, joint research, and drug development and drug harmonization activities.

Producing nearly 150 peer-reviewed publications in the last five years, the Lamy Center has established a national reputation for high-quality research, particularly in the areas of Medicare drug policy, nursing home pharmacy, and medication quality and adherence in elderly patients with chronic disease.

Funding totaled more than

Partner Organizations

$10 million

• US/Thai Consortium for the Development of Pharmacy Education

• Shanghai Jiao Tong University • Medical Counter Measures Against Radiological and Nuclear Threats

60 PROJECTS

• University of Antwerp

from a large variety of sources including NIH, NIA, AHRQ, other federal agencies, state government, Baltimore City, foundations, and private industry

were funded during the last five years to research aging-related issues

• Chonbuk National University • The Research Network • Ukranian National University of Pharmacy • Chinese Bureau of Drugs and Medicine • Botanical Society of Yunnan

Bruce Stuart, PhD, professor of pharmaceutical health services research and executive director of the center, was selected to serve as a commissioner on the Congressional Medicare Payment Advisory Commission (MedPAC) 2008-2012.

Nicole Brandt, PharmD, professor of pharmacy practice and science, was named president of the American Society of Consultant Pharmacists for 2015-2016 and served on Beers Criteria panel in 2012.

• Saudi Arabian Cultural Mission • Guangixi University of Chinese Medicine • Oman Pharmacy Institute • Globalization of Pharmaceutics Education Network

PATIENT-CENTERED OUTCOMES RESEARCH (PCOR)

tered Involvement in Evaluating the effectiveNess

The School of Pharmacy is spearheading a close collaboration among researchers from UMB’s schools of pharmacy, medicine, nursing, social work, dentistry, and law, the University of Maryland, College Park, community associations, churches, advocacy groups, hospitals, health care systems, and, of course, patients.

M-CERSI

2011

The program, called PATIENTS (PATient-cenof TreatmentS) received a $5

million grant

from the Agency for Healthcare Research and Quality in 2013 and is directed by C. Daniel Mullins, PhD, professor and chair of pharmaceutical health services research.

The University of Maryland established a Center of Excellence in Regulatory Science and Innovation (M-CERSI) with an initial $1 million grant from the FDA. The center is co-directed by James Polli, PhD, professor of pharmaceutical sciences.

M-CERSI, with its collaboration among academia, industry, and government, provides a unique opportunity to impact patient health.

School of Pharmacy’s MS in Regulatory Science launched, which prepares students to meet the increasing demand for skilled regulatory scientists.

2014

GRANT AND CONTRACT FUNDING

The School has seen continued growth in its overall grant and contract funding and in the diversity of its funding sources.

The School’s success in obtaining NIH grants remains a point of pride, with more than $5 million in funding from the NIH in FY14

FDA GRANTS AND CONTRACTS FY14

$24.5M

FY13

$20.2M

FY12

$18M

FY11

$16.6M

FY10

$16.4M

Over the last five years, the School has secured nearly

$6 million in grants and contracts from the Food and Drug Administration for projects such as:

examining formulation effects on abuse deterrence properties in solid oral dosage forms of opioids developing quantitative pharmacometric models to advance the evaluation of generic drugs, specifically in the areas of narrow therapeutic index (NTI) drugs, generic drug substitutability, and post-marketing risk assessment examining the effectiveness of brand versus generic iron medications used to treat anemia in kidney disease patients pharmacokinetic studies of epileptic drugs post-marketing surveillance of generic drug usage and substitution patterns heat effect on generic transdermal drug delivery systems

MASS SPECTROMETRY

The Mass Spectrometry Center, directed by Maureen Kane, PhD, associate professor of pharmaceutical sciences, provides expertise, methodology, and instrumentation to School of Pharmacy researchers and the global research community through its proteomics, metabolomics, and imaging capabilities.

2013

DESIGNATED A PARTNER IN WATERS CORPORATION’S CENTER OF INNOVATION PROGRAM

RECEIVED UNIVERSITY CENTER STATUS FIELDS 13 BIOMEDICAL OF EXPERTISE

17

The Center helped UMB researchers secure $98 million in grants, contracts, and subcontracts in FY14

MASS SPECTROMETERS ON-SITE

70

APPROX. PROJECTS DONE FOR EXTERNAL RESEARCHERS SINCE FOUNDING IN 2010

ENTREPRENEURSHIP Our focus on entrepreneurship allows faculty to be directly responsible for developing technology and provides new, nontraditional funding for the School. There’s an important educational component, too, that students can learn about the process of entrepreneurship and understanding it as a possible career path.

— DEAN NATALIE D. EDDINGTON, PHD ’89, BSP, FAAPS, FCP

TRANSLATIONAL RESEARCH 2011

5

STARTUPS

David Goodlett, PhD Deurion and Pataigin Alex MacKerell, PhD SILCSBio Audra Stinchcomb, PhD Alltranz and F6 Bio

59 83 13

INVENTION DISCLOSURES

PATENT APPLICATIONS

Formed Center for Translational Medicine (CTM), directed by Joga Gobburu, PhD, professor of pharmacy practice and science

2012

Started the Master of Science in Pharmacometrics

2014

CTM received a $1.7 million in-kind gift from Certara to aid in its educational and research initiatives.

2015

CTM received $1.2 million in FDA grants to support the development of quantitative pharmacometric models to advance the evaluation of generic drugs.

200+

CONTINUING EDUCATION The School maintains an emphasis on continuing education (CE) for pharmacy practitioners.

CE participation reached an all-time high in 2014

PROGRAMS

FACULTY PATENTS, STARTUPS, AND INVENTIONS 2010-2014

83

32%

Alumni & Preceptors

PATENTS 3,367 PARTICIPANTS

2010

2014

ENVIRONMENT

STUDENT SATISFACTION SENSE OF COMMUNITY IN THE SCHOOL LEADERSHIP OPPORTUNITIES ACTIVE IN STUDENT ORGANIZATION OFFICEHOLDER IN STUDENT ORGANIZATION

80% 90% 85% 58%

JOB READINESS INITIATIVES

School of Pharmacy students have always been well-prepared to apply the skills they’ve learned in the classroom and the laboratory to postgraduate jobs in the workforce. But with the stubborn recession that descended on the American workforce in 2008 came a much tighter job market, including in the pharmacy profession.

2011

JOB READY PROGRAM LAUNCHED

We’ve had an explosion of new schools of pharmacy and

Job readiness activities include resume and CV writing workshops, mock interviewing sessions with alumni, internship, residency and career fairs, research career roundtables, visits to industry, and more.

More than 1,500 students participated in almost 60 events from 2012 to 2014.

with that there has been a decrease in the total number of pharmacy positions around the country. We thought it was important to develop a program focused on career development and professionalism skills.

— DEAN NATALIE D. EDDINGTON, PHD ’89, BSP, FAAPS, FCP

MAJOR FACULTY APPOINTMENTS AND STUDENT AWARDS Sampling of Faculty and Staff Appointments from the Last Five Years Accreditation Council for Pharmacy Education President Member, International Commission Agency for Healthcare Research and Quality Standing member, study section Alumni Association International President-elect American Academy of Hospice and Palliative Medicine Founding chair, Pharmacotherapy Special Interest Group American Association of Colleges of Pharmacy Board member Chair-elect, Council of Deans Chair, Student Services SIG Chair, Ethics SIG Chair, Research and Graduate Affairs Standing Committee Chair, Professional Affairs Committee Chair-elect, Administrative Services Section Member-at-large, Eastern Region of the Administration and Finance SIG Robert K. Chalmers Teacher of the Year Awards Excellence in Assessment Award American Association of Pharmaceutical Scientists Fellows Executive Council member- at-large Distinguished Service Award American Association of Poison Control Centers Chair, Research Awards Committee American College of Clinical Pharmacy Fellows Secretary/Treasurer, Pain and Palliative Care Practice and Research Network American Heart Association Fellow American Pain Society Member, Educational Advisory Board American Pharmacists Association Member, Foundation Board of Directors

Member, Community Pharmacy Advisory Panel Member, Academy of Pharmacy Practice and Management Awards Standing Committee Fellow Member, New Practitioners Network’s Education and Professional Development Standing Committee Members, Academy of Pharmaceutical Research and Science Communications Standing Committee Daniel B. Smith Practice Excellence Award Community Pharmacy Residency Excellence in Precepting Award Distinguished New Practitioner Award American Society for Clinical Pharmacology and Therapeutics Chair, Pharmacometrics and Pharmacokinetics Section American Society for Pharmacy Law President American Society of Consultant Pharmacists President-elect Fellow Member, Pharmacy Educators Council Member, Maryland Chapter Board of Directors George F. Archambault Award American Society of Health-System Pharmacists Fellow Chair, House of Delegates Member, Board of Directors Member, Section Advisory Group American Society of Pain Educators President Member, Board of Directors Fellow Board of Pharmacy Specialties Pharmacist special member Member, Practice Analysis Taskforce in Cardiology College of Psychiatric and Neurologic Pharmacists President-elect

College on Problems of Drug Dependence Board member Fellow Critical Care Pharmacotherapy Trials Network Member, proposals and grants review committee Delmarva Foundation for Medical Care Board member Eastern States Residency Advisory Board Member Chair-elect, Residency Conference Editorial Entities American Journal of Pharmaceutical Education, editorial board Value in Health, co-editor-in- chief Pharmacoeconomics, editorial board Ethnicity & Disease, editorial board Drug Metabolism and Disposition, associate editor Pharmacotherapy, science editor Journal of Managed Care Pharmacy, assistant editor Food and Drug Law, editorial board Journal of Gerontological Nursing, column editor Practical Pain Management, editorial board British Medical Journal, associate editor Pharmacy Today, editorial board Caring for the Ages, pharmacy columnist Food and Drug Administration Advisory committee members Health Literacy Maryland Coalition Secretary, Executive Committee International Pharmaceutical Federation Member, Section Advisory Council Leader, Continuing Professional Development Domain

IN THE LAST FIVE YEARS, THE NUMBER OF NATIONAL RECOGNITIONS/AWARDS FOR ACADEMIC EXCELLENCE FOR BOTH FACULTY AND STUDENTS HAS NEARLY DOUBLED. International Society for National Academy of Practice Pharmacoepidemiology Distinguished Practitioners Fellow Chair, Pharmacy Academy International Society for National Center for Youth Law Pharmacoeconomics and Outcomes Member, Board of Directors Research National Commission for Member, Task Force Certification Chair, Student Chapter Committee member, Geriatric Faculty Advisor Council Pharmacy Exam Development International Society of Quantum National Hospice and Palliative Care Biology and Pharmacology Organization Member, Advisory Board Member, Part D Medication Maryland Board of Pharmacy Relatedness National Commissioner-at-large Working Group Maryland Council for Overdose National Institute for Pharmaceutical Prevention Technology and Education Member Chair, Board of Directors Maryland Department of Health and National Institutes of Health Mental Hygiene Chair, Study Section Subcommittee member, Members, Study Sections Maryland Health Care Reform Network 2000 Coordinating Council Vice president Executive committee Obesity Society member, Asthma Control Member, Early Career program Investigator Committee Maryland Medicaid Drug Utilization Oregon State University Review Board Icon of Pharmacy Award Member Palliative Care Research Cooperative Maryland Pharmacists Association Member President Pharmacy Quality Alliance Honorary president Member, Mental Health Trustee Work Group Co-chair, New Practitioners Member, Board of Directors Network Quality Health Foundation Maryland Public Health Association Member, Board of Directors President Sleep Research Society Maryland Society of Health-System Member, Membership and Pharmacists Communication Committee President Society of Critical Care Medicine Members, Board of Directors Task force member Chair, committees Chair, Clinical Pharmacy Maryland State Advisory Council on and Pharmacology Arthritis and Related Diseases Education Subcommittee Member Third International Conference on Maryland State Advisory Council on Microneedles Heart Disease and Stroke Chair Chair United States Pharmacopeia Maryland State Council for End of Convention Life Care Member, expert committee Committee member University of Rhode Island College Maryland State Overdose Advisory of Pharmacy Council Member, Advisory Board Member University System of Maryland Medicare Payment Advisory Council of University System Commission Staff, Co-secretary Member

SIGNIFICANT STUDENT HONORS FROM THE LAST FIVE YEARS: Agency for Healthcare Research and Quality Health Services Research Dissertation Award American Chemical Society Fellowships American College of Clinical Pharmacy Wayne A. Colburn Award American Foundation for Pharmaceutical Education Fellowships American Pharmacists Association’s Operation Heart and Operation Immunization Region 2 Award American Society of Consultant Pharmacists’

Maryland Chapter Student of the Year American Society of Health-System Pharmacists’ Student Leadership Award Baltimore Albert Schweitzer Fellowships CVS Caremark Outstanding Intern Award Globalization of Pharmaceutics Education Network Podium Award International Society for Pharmacoeconomics and Outcomes Research Distinguished Service Award Lambda Kappa Sigma Professional Pharmacy

Fraternity Outstanding Collegiate Chapter and Outstanding Alumni Chapter Lee B. Lusted Student Prize in Applied Health Economics from the Society of Medical Decision Making MedImmune Fellowships National Kappa Psi Pharmaceutical Fraternity Outstanding Community Service Award and Collegiate Chapter of the Year National Institutes of Health Training Grants National Research Service Fellowships

Script Your Future National Medication Adherence Team Challenge Winners U.S. Department of Health and Human Services’ Paul Ambrose Scholar United States Pharmacopeia Research Fellowships University of Maryland, Baltimore County Meyerhoff Fellowships University of Maryland, Baltimore President’s Fellowships World Health Organization Internships

SCHOOL OF PHARMACY

AT A GLANCE Founded 1841

5 DEGREES

90

OFFERED

FULL-TIME FACULTY

890

CURRENT STUDENTS AND TRAINEES

PharmD, two PhDs, two MS degrees

6 DUAL DEGREES

60

OFFERED

PharmD/MBA, PharmD/PhD, PharmD/JD, PharmD/MPH, PharmD/MS, and PhD/MS

AFFILIATE FACULTY

896

PRECEPTOR FACULTY

20132014

11

DESIGNATED RESEARCH, PRACTICE, AND EDUCATION CENTERS

$56.9 MILLION

Total operating revenue

ALUMNI 3,302 MARYLAND IN-STATE ALUMNI

5,239

ALL ALUMNI by degree* PharmD BSP

PhD

MS

2,513 2,392 422 273 *Some alumni have achieved multiple degrees

ACTIVE ALUMNI

PEOPLE “LIKE” US!

Our social media presence is consistently on the rise:

TWITTER FOLLOWERS FACEBOOK “LIKES”

16

cap s u le

www.pharmacy.umaryland.edu

March 2015

4,353

March 2014

3,314

March 2013

1,873

March 2012

980

March 2011

614

April 2015

933

April 2014

644

April 2013

444

April 2012

245

April 2011

140